Castelli Jeff

Amicus Therapeutics, Inc.

Chief Development Officer

Avg. Two Year Performance

15% Avg. Purchase Return 7% Compound

25% Avg. Sale Return 12% Compound

Holdings: 362.8K shares

Last Three Months: 26-Aug-24 -- 25-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions